cember 31, 2005, in those countries classified by the 
World Health Organization as among the highest tuber-
culosis burden, and not later than December 31, 2010, 
in all countries in which the United States Agency for 
International Development has established development 
programs. 
‘‘(c) AUTHORIZATION.—To carry out this section and 
consistent with section 104(c), the President is authorized 
to furnish assistance, on such terms and conditions as the 
President may determine, for the prevention, treatment, 
control, and elimination of tuberculosis. 
‘‘(d) COORDINATION.—In carrying out this section, 
the President shall coordinate with the World Health Or-
ganization, the Global Fund to Fight AIDS, Tuberculosis, 
and Malaria, and other organizations with respect to the 
development and implementation of a comprehensive tu-
berculosis control program. 
‘‘(e) PRIORITY TO DOTS COVERAGE.—In furnishing 
assistance under subsection (c), the President shall give 
priority to activities that increase Directly Observed 
Treatment Short-course (DOTS) coverage and treatment 
of multi-drug resistant tuberculosis where needed using 
DOTS-Plus, including funding for the Global Tuberculosis 
Drug Facility, the Stop Tuberculosis Partnership, and the 
Global Alliance for TB Drug Development.
‘‘(f) DEFINITIONS.—In this section: 
‘‘(1) DOTS.—The term ‘DOTS’ or ‘Directly 
Observed Treatment Short-course’ means the World 
Health 
Organization-recommended 
strategy 
for 
treating tuberculosis. 
‘‘(2) DOTS-PLUS.—The term ‘DOTS-Plus’ 
means a comprehensive tuberculosis management 
strategy that is built upon and works as a supple-
ment to the standard DOTS strategy, and which 
takes into account specific issues (such as use of sec-
ond line anti-tuberculosis drugs) that need to be ad-
dressed in areas where there is high prevalence of 
multi-drug resistant tuberculosis. 
‘‘(3) GLOBAL
ALLIANCE
FOR
TUBERCULOSIS 
DRUG
DEVELOPMENT.—The term ‘Global Alliance 
for Tuberculosis Drug Development’ means the pub-
lic-private partnership that brings together leaders 
in health, science, philanthropy, and private industry 
to devise new approaches to tuberculosis and to en-
sure that new medications are available and afford-
able in high tuberculosis burden countries and other 
affected countries. 
‘‘(4) GLOBAL
TUBERCULOSIS
DRUG
FACIL-
ITY.—The term ‘Global Tuberculosis Drug Facility 
(GDF)’ means the new initiative of the Stop Tuber-
culosis Partnership to increase access to high-quality 
tuberculosis drugs to facilitate DOTS expansion. 
‘‘(5) STOP TUBERCULOSIS PARTNERSHIP.—The 
term ‘Stop Tuberculosis Partnership’ means the 
partnership of the World Health Organization, do-
nors including the United States, high tuberculosis 
burden countries, multilateral agencies, and non-
governmental and technical agencies committed to 
short- and long-term measures required to control 
and eventually eliminate tuberculosis as a public 
health problem in the world.’’. 
(b) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to funds avail-
able under section 104(c) of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151b(c)) for such purpose 
or under any other provision of that Act, there are 
authorized to be appropriated to the President, from 
amounts authorized to be appropriated under section 
401, such sums as may be necessary for each of the 
fiscal years 2004 through 2008 to carry out section 
104B of the Foreign Assistance Act of 1961, as 
added by subsection (a). 
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to the authorization of appropria-
tions under paragraph (1) are authorized to remain 
available until expended. 
(3) TRANSFER OF PRIOR YEAR FUNDS.—Unob-
ligated balances of funds made available for fiscal 
year 2001, 2002, or 2003 under section 104(c)(7) of 
the Foreign Assistance Act of 1961 (22 U.S.C. 
2151b(c)(7) (as in effect immediately before the date 
of enactment of this Act) shall be transferred to, 
merged with, and made available for the same pur-
poses as funds made available for fiscal years 2004 
through 2008 under paragraph (1). 
SEC. 303. ASSISTANCE TO COMBAT MALARIA. 
(a) AMENDMENT OF THE FOREIGN ASSISTANCE ACT 
OF 1961.—Chapter 1 of part I of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151 et seq.), as amended by sec-
tions 301 and 302 of this Act, is further amended by in-
serting after section 104B the following new section: 
‘‘SEC. 104C. ASSISTANCE TO COMBAT MALARIA. 
‘‘(a) FINDING.—Congress finds that malaria kills 
more people annually than any other communicable dis-
ease except tuberculosis, that more than 90 percent of all 
malaria cases are in sub-Saharan Africa, and that children 
and women are particularly at risk. Congress recognizes 
that there are cost-effective tools to decrease the spread
of malaria and that malaria is a curable disease if prompt-
ly diagnosed and adequately treated. 
‘‘(b) POLICY.—It is a major objective of the foreign 
assistance program of the United States to provide assist-
ance for the prevention, control, and cure of malaria. 
‘‘(c) AUTHORIZATION.—To carry out this section and 
consistent with section 104(c), the President is authorized 
to furnish assistance, on such terms and conditions as the 
President may determine, for the prevention, treatment, 
control, and elimination of malaria. 
‘‘(d) COORDINATION.—In carrying out this section, 
the President shall coordinate with the World Health Or-
ganization, the Global Fund to Fight AIDS, Tuberculosis, 
and Malaria, the Department of Health and Human Serv-
ices (the Centers for Disease Control and Prevention and 
the National Institutes of Health), and other organiza-
tions with respect to the development and implementation 
of a comprehensive malaria control program.’’. 
(b) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to funds avail-
able under section 104(c) of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151b(c)) for such purpose 
or under any other provision of that Act, there are 
authorized to be appropriated to the President, from 
amounts authorized to be appropriated under section
401, such sums as may be necessary for fiscal years 
2004 through 2008 to carry out section 104C of the 
Foreign Assistance Act of 1961, as added by sub-
section (a). 
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to paragraph (1) are authorized to 
remain available until expended. 
(3) TRANSFER OF PRIOR YEAR FUNDS.—Unob-
ligated balances of funds made available for fiscal 
year 2001, 2002, or 2003 under section 104(c) of 
the Foreign Assistance Act of 1961 (22 U.S.C. 
2151b(c) (as in effect immediately before the date of 
enactment of this Act) and made available for the 
control of malaria shall be transferred to, merged 
with, and made available for the same purposes as 
funds made available for fiscal years 2004 through 
2008 under paragraph (1). 
(c) CONFORMING AMENDMENT.—Section 104(c) of 
the Foreign Assistance Act of 1961 (22 U.S.C. 2151b(c)), 
as amended by section 301 of this Act, is further amended 
by adding after paragraph (3) the following: 
‘‘(4) RELATIONSHIP TO OTHER LAWS.—Assist-
ance made available under this subsection and sec-
tions 104A, 104B, and 104C, and assistance made 
available under chapter 4 of part II to carry out the
purposes of this subsection and the provisions cited 
in this paragraph, may be made available notwith-
standing any other provision of law, except for the 
provisions of this subsection, the provisions of law 
cited in this paragraph, subsection (f), and section 
634A of this Act.’’.
SEC. 304. PILOT PROGRAM FOR THE PLACEMENT OF 
HEALTH CARE PROFESSIONALS IN OVERSEAS 
AREAS SEVERELY AFFECTED BY HIV/AIDS, 
TUBERCULOSIS, AND MALARIA. 
(a) IN GENERAL.—The President shall establish a 
program to demonstrate the feasibility of facilitating the 
service of United States health care professionals in those 
areas of sub-Saharan Africa and other parts of the world 
severely affected by HIV/AIDS, tuberculosis, and malaria. 
(b) REQUIREMENTS.—Participants in the program 
shall—
(1) provide basic health care services for those 
infected and affected by HIV/AIDS, tuberculosis, 
and malaria in the area in which they are serving; 
(2) provide on-the-job training to medical and 
other personnel in the area in which they are serving 
to strengthen the basic health care system of the af-
fected countries;
(3) provide health care educational training for 
residents of the area in which they are serving; 
(4) serve for a period of up to three years; and 
(5) meet the eligibility requirements in sub-
section (d). 
(c) ELIGIBILITY REQUIREMENTS.—To be eligible to 
participate in the program, a candidate shall—
(1) be a national of the United States who is 
a trained health care professional and who meets the 
educational and licensure requirements necessary to 
be such a professional such as a physician, nurse, 
nurse practitioner, pharmacist, other type of health 
care professional, or other individual determined to 
be appropriate by the President; or 
(2) a retired commissioned officer of the Public 
Health Service Corps. 
(d) RECRUITMENT.—The President shall ensure that 
information on the program is widely distributed, includ-
ing the distribution of information to schools for health 
professionals, hospitals, clinics, and nongovernmental or-
ganizations working in the areas of international health 
and aid. 
(e) PLACEMENT OF PARTICIPANTS.—
(1) IN
GENERAL.—To the maximum extent 
practicable, participants in the program shall serve
in the poorest areas of the affected countries, where 
health care needs are likely to be the greatest. The 
decision on the placement of a participant should be 
made in consultation with relevant officials of the af-
fected country at both the national and local level as 
well as with local community leaders and organiza-
tions. 
(2) COORDINATION.—Placement of participants 
in the program shall be coordinated with the United 
States Agency for International Development in 
countries in which that Agency is conducting HIV/
AIDS, tuberculosis, or malaria programs. Overall co-
ordination of placement of participants in the pro-
gram shall be made by the Coordinator of United 
States Government Activities to Combat HIV/AIDS 
Globally (as described in section 1(f) of the State 
Department Basic Authorities Act of 1956 (as 
added by section 102(a) of this Act)). 
(f) INCENTIVES.—The President may offer such in-
centives as the President determines to be necessary to 
encourage individuals to participate in the program, such 
as partial payment of principal, interest, and related ex-
penses on government and commercial loans for edu-
cational expenses relating to professional health training 
and, where possible, deferment of repayments on such
loans, the provision of retirement benefits that would oth-
erwise be jeopardized by participation in the program, and 
other incentives. 
(g) REPORT.—Not later than 18 months after the 
date of enactment of this Act, the President shall submit 
to the appropriate congressional committees a report on 
steps taken to establish the program, including—
(1) the process of recruitment, including the 
venues for recruitment, the number of candidates re-
cruited, the incentives offered, if any, and the cost 
of those incentives; 
(2) the process, including the criteria used, for 
the selection of participants; 
(3) the number of participants placed, the coun-
tries in which they were placed, and why those coun-
tries were selected; and 
(4) the potential for expansion of the program. 
(h) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to amounts oth-
erwise available for such purpose, there are author-
ized to be appropriated to the President, from 
amounts authorized to be appropriated under section 
401, such sums as may be necessary for each of the 
fiscal years 2004 through 2008 to carry out the pro-
gram.
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to the authorization of appropria-
tions under paragraph (1) are authorized to remain 
available until expended. 
SEC. 305. REPORT ON TREATMENT ACTIVITIES BY REL-
EVANT EXECUTIVE BRANCH AGENCIES. 
(a) IN GENERAL.—Not later than 15 months after 
the date of enactment of this Act, the President shall sub-
mit to appropriate congressional committees a report on 
the programs and activities of the relevant executive 
branch agencies that are directed to the treatment of indi-
viduals in foreign countries infected with HIV or living 
with AIDS. 
(b) REPORT ELEMENTS.—The report shall include—
(1) a description of the activities of relevant ex-
ecutive branch agencies with respect to—
(A) the treatment of opportunistic infec-
tions; 
(B) the use of antiretrovirals; 
(C) the status of research into successful 
treatment protocols for individuals in the devel-
oping world; and 
(D) technical assistance and training of 
local health care workers (in countries affected 
by the pandemic) to administer antiretrovirals,
manage side effects, and monitor patients’ viral 
loads and immune status; 
(2) information on existing pilot projects, in-
cluding a discussion of why a given population was 
selected, the number of people treated, the cost of 
treatment, the mechanisms established to ensure 
that treatment is being administered effectively and 
safely, and plans for scaling up pilot projects (in-
cluding projected timelines and required resources); 
and 
(3) an explanation of how those activities relate 
to efforts to prevent the transmission of the HIV in-
fection. 
Subtitle B—Assistance for Children 
and Families 
SEC. 311. FINDINGS. 
Congress makes the following findings: 
(1) Approximately 2,000 children around the 
world are infected each day with HIV through moth-
er-to-child transmission. Transmission can occur 
during pregnancy, labor, and delivery or through 
breast feeding. Over ninety percent of these cases 
are in developing nations with little or no access to 
public health facilities.
(2) Mother-to-child transmission is largely pre-
ventable with the proper application of pharma-
ceuticals, therapies, and other public health interven-
tions. 
(3) The drug nevirapine reduces mother-to-child 
transmission by nearly 50 percent. Universal avail-
ability of this drug could prevent up to 400,000 in-
fections per year and dramatically reduce the num-
ber of AIDS-related deaths. 
(4) At the United Nations Special Session on 
HIV/AIDS in June 2001, the United States com-
mitted to the specific goals with respect to the pre-
vention of mother-to-child transmission, including 
the goals of reducing the proportion of infants in-
fected with HIV by 20 percent by the year 2005 and 
by 50 percent by the year 2010, as specified in the 
Declaration of Commitment on HIV/AIDS adopted 
by the United Nations General Assembly at the Spe-
cial Session. 
(5) Several United States Government agencies 
including the United States Agency for International 
Development and the Centers for Disease Control 
are already supporting programs to prevent mother-
to-child transmission in resource-poor nations and 
have the capacity to expand these programs rapidly
by working closely with foreign governments and 
nongovernmental organizations. 
(6) Efforts to prevent mother-to-child trans-
mission can provide the basis for a broader response 
that includes care and treatment of mothers, fa-
thers, and other family members who are infected 
with HIV or living with AIDS. 
(7) HIV/AIDS has devastated the lives of 
countless children and families across the globe. 
Since the epidemic began, an estimated 13,200,000 
children under the age of 15 have been orphaned by 
AIDS, that is they have lost their mother or both 
parents to the disease. The Joint United Nations 
Program on HIV/AIDS (UNAIDS) estimates that 
this number will double by the year 2010. 
(8) HIV/AIDS also targets young people be-
tween the ages of 15 to 24, particularly young 
women, many of whom carry the burden of caring 
for family members living with HIV/AIDS. An esti-
mated 10,300,000 young people are now living with 
HIV/AIDS. One-half of all new infections are occur-
ring among this age group. 
SEC. 312. POLICY AND REQUIREMENTS. 
(a) POLICY.—The United States Government’s re-
sponse to the global HIV/AIDS pandemic should place
high priority on the prevention of mother-to-child trans-
mission, the care and treatment of family members and 
caregivers, and the care of children orphaned by AIDS. 
To the maximum extent possible, the United States Gov-
ernment should seek to leverage its funds by seeking 
matching contributions from the private sector, other na-
tional governments, and international organizations. 
(b) REQUIREMENTS.—The 5-year United States Gov-
ernment strategy required by section 101 of this Act 
shall—
(1) provide for meeting or exceeding the goal to 
reduce the rate of mother-to-child transmission of 
HIV by 20 percent by 2005 and by 50 percent by 
2010; 
(2) include programs to make available testing 
and treatment to HIV-positive women and their 
family members, including drug treatment and 
therapies to prevent mother-to-child transmission; 
and 
(3) expand programs designed to care for chil-
dren orphaned by AIDS.
SEC. 313. ANNUAL REPORTS ON PREVENTION OF MOTHER-
TO-CHILD TRANSMISSION OF THE HIV INFEC-
TION. 
(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this Act, and annually thereafter 
for a period of five years, the President shall submit to 
appropriate congressional committees a report on the ac-
tivities of relevant executive branch agencies during the 
reporting period to assist in the prevention of mother-to-
child transmission of the HIV infection. 
(b) REPORT ELEMENTS.—Each report shall in-
clude—
(1) a statement of whether or not all relevant 
executive branch agencies have met the goal de-
scribed in section 312(b)(1); and 
(2) a description of efforts made by the relevant 
executive branch agencies to expand those activities, 
including—
(A) information on the number of sites 
supported for the prevention of mother-to-child 
transmission of the HIV infection; 
(B) the specific activities supported; 
(C) the number of women tested and coun-
seled; and 
(D) the number of women receiving pre-
ventative drug therapies.
(c) REPORTING PERIOD DEFINED.—In this section, 
the term ‘‘reporting period’’ means, in the case of the ini-
tial report, the period since the date of enactment of this 
Act and, in the case of any subsequent report, the period 
since the date of submission of the most recent report. 
SEC. 314. PILOT PROGRAM OF ASSISTANCE FOR CHILDREN 
AND FAMILIES AFFECTED BY HIV/AIDS. 
(a) IN GENERAL.—The President, acting through the 
United States Agency for International Development, 
should establish a program of assistance that would dem-
onstrate the feasibility of the provision of care and treat-
ment to orphans and other children and young people af-
fected by HIV/AIDS in foreign countries. 
(b) 
PROGRAM
REQUIREMENTS.—The 
program 
should—
(1) build upon and be integrated into programs 
administered as of the date of enactment of this Act 
by the relevant executive branch agencies for chil-
dren affected by HIV/AIDS; 
(2) work in conjunction with indigenous com-
munity-based programs and activities, particularly 
those that offer proven services for children; 
(3) reduce the stigma of HIV/AIDS to encour-
age vulnerable children infected with HIV or living 
with AIDS and their family members and caregivers
to avail themselves of voluntary counseling and test-
ing, and related programs, including treatments; 
(4) provide, in conjunction with other relevant 
executive branch agencies, the range of services for 
the care and treatment, including the provision of 
antiretrovirals and other necessary pharmaceuticals, 
of children, parents, and caregivers infected with 
HIV or living with AIDS; 
(5) provide nutritional support and food secu-
rity, and the improvement of overall family health; 
(6) work with parents, caregivers, and commu-
nity-based organizations to provide children with 
educational opportunities; and 
(7) provide appropriate counseling and legal as-
sistance for the appointment of guardians and the 
handling of other issues relating to the protection of 
children. 
(c) REPORT.—Not later than 18 months after the 
date of enactment of this Act, the President should submit 
a report on the implementation of this section to the ap-
propriate congressional committees. 
(d) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to amounts oth-
erwise available for such purpose, there are author-
ized to be appropriated to the President, from
amounts authorized to be appropriated under section 
401, such sums as may be necessary for each of the 
fiscal years 2004 through 2008 to carry out the pro-
gram. 
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to paragraph (1) are authorized to 
remain available until expended. 
SEC. 315. PILOT PROGRAM ON FAMILY SURVIVAL PART-
NERSHIPS. 
(a) PURPOSE.—The purpose of this section is to au-
thorize the President to establish a program, through a 
public-private partnership, for the provision of medical 
care and support services to HIV positive parents and 
their children identified through existing programs to pre-
vent mother-to-child transmission of HIV in countries 
with or at risk for severe HIV epidemic with particular 
attention to resource constrained countries. 
(b) GRANTS.—
(1) IN GENERAL.—The President is authorized 
to establish a program for the award of grants to el-
igible administrative organizations to enable such or-
ganizations to award subgrants to eligible entities to 
expand activities to prevent the mother-to-child 
transmission of HIV by providing medical care and
support services to HIV infected parents and their 
children. 
(2) USE OF FUNDS.—Amounts provided under 
a grant awarded under paragraph (1) shall be 
used—
(A) to award subgrants to eligible entities 
to enable such entities to carry out activities de-
scribed in subsection (c); 
(B) 
for 
administrative 
support 
and 
subgrant management; 
(C) for administrative data collection and 
reporting concerning grant activities; 
(D) for the monitoring and evaluation of 
grant activities; 
(E) for training and technical assistance 
for subgrantees; and 
(F) to promote sustainability. 
(c) SUBGRANTS.—
(1) IN GENERAL.—An organization awarded a 
grant under subsection (b) shall use amounts re-
ceived under the grant to award subgrants to eligible 
entities. 
(2) ELIGIBILITY.—To be eligible to receive a 
subgrant under paragraph (1), an entity shall—
(A) be a local health organization, an 
international organization, or a partnership of 
such organizations; and 
(B) demonstrate to the awarding organiza-
tion that such entity—
(i) is currently administering a proven 
intervention to prevent mother-to-child 
transmission of HIV in countries with or 
at risk for severe HIV epidemic with par-
ticular attention to resource constrained 
countries, as determined by the President; 
(ii) has demonstrated support for the 
proposed program from relevant govern-
ment entities; and 
(iii) is able to provide HIV care, in-
cluding 
antiretroviral 
treatment 
when 
medically 
indicated, 
to 
HIV 
positive 
women, men, and children with the support 
of the project funding. 
(3) LOCAL HEALTH AND INTERNATIONAL OR-
GANIZATIONS.—For purposes of paragraph (2)(A)—
(A) the term ‘‘local health organization’’ 
means a public sector health system, non-
governmental organization, institution of higher 
education, community-based organization, or
nonprofit health system that provides directly, 
or has a clear link with a provider for the indi-
rect provision of, primary health care services; 
and 
(B) the term ‘‘international organization’’ 
means—
(i) a nonprofit international entity; 
(ii) an international charitable institu-
tion; 
(iii) a private voluntary international 
entity; or 
(iv) a multilateral institution. 
(4) SELECTION OF SUBGRANT RECIPIENTS.—In 
awarding subgrants under this subsection, the orga-
nization should—
(A) consider applicants from a range of 
health care settings, program approaches, and 
geographic locations; and 
(B) if appropriate, award not less than 1 
grant to an applicant to fund a national system 
of health care delivery to HIV positive families. 
(5) USE OF SUBGRANT FUNDS.—An eligible en-
tity awarded a subgrant under this subsection shall 
use subgrant funds to expand activities to prevent 
mother-to-child transmission of HIV by providing
medical treatment and care and support services to 
parents and their children, which may include—
(A) providing treatment and therapy, when 
medically indicated, to HIV-infected women, 
their children, and families; 
(B) the hiring and training of local per-
sonnel, including physicians, nurses, other 
health care providers, counselors, social work-
ers, outreach personnel, laboratory technicians, 
data managers, and administrative support per-
sonnel; 
(C) paying laboratory costs, including costs 
related to necessary equipment and diagnostic 
testing and monitoring (including rapid test-
ing), complete blood counts, standard chem-
istries, and liver function testing for infants, 
children, and parents, and costs related to the 
purchase of necessary laboratory equipment; 
(D) purchasing pharmaceuticals for HIV-
related 
conditions, 
including 
antiretroviral 
therapies; 
(E) funding support services, including ad-
herence and psychosocial support services; 
(F) operational support activities; and
(G) conducting community outreach and 
capacity building activities, including activities 
to raise the awareness of individuals of the pro-
gram carried out by the subgrantee, other com-
munications activities in support of the pro-
gram, local advisory board functions, and trans-
portation necessary to ensure program partici-
pation. 
(d) REPORTS.—The President shall require that each 
organization awarded a grant under subsection (b)(1) to 
submit an annual report that includes—
(1) the progress of programs funded under this 
section; 
(2) the benchmarks of success of programs 
funded under this section; and 
(3) recommendations of how best to proceed 
with the programs funded under this section upon 
the expiration of funding under subsection (e). 
(e) FUNDING.—There are authorized to be appro-
priated to the President, from amounts authorized to be 
appropriated under section 401, such sums as may be nec-
essary for each of the fiscal years 2004 through 2008 to 
carry out the program. 
(f) LIMITATION ON ADMINISTRATIVE EXPENSES.—
An organization shall ensure that not more than 7 percent
of the amount of a grant received under this section by 
the organization is used for administrative expenses. 
TITLE IV—AUTHORIZATION OF 
APPROPRIATIONS 
SEC. 401. AUTHORIZATION OF APPROPRIATIONS. 
(a) IN GENERAL.—There are authorized to be appro-
priated to the President to carry out this Act and the 
amendments made by this Act $3,000,000,000 for each 
of the fiscal years 2004 through 2008. 
(b) AVAILABILITY.—Amounts appropriated pursuant 
to the authorization of appropriations in subsection (a) are 
authorized to remain available until expended. 
(c) AVAILABILITY OF AUTHORIZATIONS.—Authoriza-
tions of appropriations under subsection (a) shall remain 
available until the appropriations are made. 
SEC. 402. SENSE OF CONGRESS. 
It is the sense of Congress that, of the amounts ap-
propriated pursuant to the authorization of appropriations 
under section 401 for HIV/AIDS assistance, an effective 
distribution of such amounts would be—
(1) 55 percent of such amounts for treatment 
of individuals with HIV/AIDS; 
(2) 15 percent of such amounts for palliative 
care of individuals with HIV/AIDS; and
(3) 20 percent of such amounts for educational 
efforts for HIV/AIDS prevention.
Æ